<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="on viral replication processes. (1) ACE2 and spike complex inhibitors:" exact="Azithromycin" post="and Chloroquine, interrupt in ACE2 and S protein complex"/>
 <result pre="cleavage and activation of the S protein; (3) Targeting endosomes:" exact="chloroquine" post="and its derivatives increase pH and inhibit viral RNA"/>
 <result pre="thereby inhibit viral replication; (5) Targeting RdRp: Favipiravir, Remdesivir, and" exact="Ribavirin" post="block RdRp and cause premature termination of RNA synthesis;"/>
 <result pre="al., 2006) and the efficacy of PLpro inhibitors such as" exact="chloroquine" post="and formoterol have been investigated recently for the treatment"/>
 <result pre="and the efficacy of PLpro inhibitors such as chloroquine and" exact="formoterol" post="have been investigated recently for the treatment of COVIDâ€�19"/>
 <result pre="Feng, Porter, &amp;amp; GÃ¶tte, 2019). Remdesivir (GSâ€�5734), a prodrug and" exact="adenosine" post="analog, can be incorporated into nascent viral RNA, and"/>
 <result pre="of TMPRSS2 in the pathogenesis of this viral disease. Previously," exact="Bromhexine" post="hydrochloride, an FDA approved component in mucolytic cough suppressants,"/>
 <result pre="reduction of the progression of metastasis (Lucas et al., 2014)." exact="Bromhexine" post="hydrochloride might be repurposed as a TMPRSS2 inhibitor for"/>
 <result pre="a potential strategy. Preliminary results from a study suggest that" exact="Hydroxychloroquine" post="might have antiâ€�cytokine storm properties (Yao et al., 2020)."/>
 <result pre="applicable Renmin Hospital of Wuhan University, Ansun Biopharma, Inc. NCT04324489" exact="Serine" post="protease inhibitor Camostat Mesilate Phase 1, phase 2 University"/>
 <result pre="1, phase 2 University of Aarhus NCT04321096 Endosome Endosomal acidification" exact="Chloroquine" post="diphosphate Phase 2 FundaÃƒÂ§ÃƒÂ£o de Medicina Tropical Dr. Heitor"/>
 <result pre="MourÃƒÂ£o, Ludmila AbrahÃƒÂ£o Hajjar, Jorge Souza MendonÃƒÂ§a NCT04323527 Endosomal acidification" exact="Chloroquine" post="or Hydroxychloroquine Not applicable University of Oxford NCT04303507 Endosomal"/>
 <result pre="AbrahÃƒÂ£o Hajjar, Jorge Souza MendonÃƒÂ§a NCT04323527 Endosomal acidification Chloroquine or" exact="Hydroxychloroquine" post="Not applicable University of Oxford NCT04303507 Endosomal acidification Colchicine"/>
 <result pre="Montreal Heart Institute, DACIMA Software NCT04322565, NCT04322682 Lysosome â€ 1" exact="Bromhexine" post="hydrochloride tablets â€ 2 Arbidol hydrochloride â€ 3 Recombinant"/>
 <result pre="Wenzhou Medical University, WanBangDe Pharmaceutical Group Co., Ltd. NCT04273763 Lysosome" exact="Hydroxychloroquine" post="Early Phase 1, Phase 2, Phase 3 National Institute"/>
 <result pre="Health Clinical Center NCT04315896, NCT04318444, NCT04318015, NCT04308668, NCT04323631, NCT04261517 Lysosome" exact="Hydroxychloroquine" post="sulfate Phase 4 University Hospital, Akershus NCT04316377 Lysosome Thalidomide"/>
 <result pre="Lysosome Hydroxychloroquine sulfate Phase 4 University Hospital, Akershus NCT04316377 Lysosome" exact="Thalidomide" post="Phase 2 First Affiliated Hospital of Wenzhou Medical University,"/>
 <result pre="Medicine, Jingmen No.1 PeopleÃ¢â‚¬â&quot;¢s Hospital, Tongji Hospital NCT04279197 Spike glycoprotein" exact="Nitric oxide" post="Phase 2 Massachusetts General Hospital, Xijing Hospital, Fondazione IRCCS"/>
 <result pre="Ca' Granda, Ospedale Maggiore Policlinico NCT04305457, NCT04306393, NCT04312243 Spike glycoprotein" exact="Nitric oxide" post="0.5%/nitrogen 99.5% gas for Inhalation Phase 2 University of"/>
 <result pre="intervention 3CLpro, interferon receptor (IFNAR) â€ 1 Lopinavir/ritonavir â€ 2" exact="Ribavirin" post="â€ 3 Interferon Betaâ€�1B Phase 2 The University of"/>
 <result pre="NCT04275388 ACE2 and spike binding complex, Endosomal acidification â€ 1" exact="Azithromycin" post="â€ 2 Chloroquine Phase 3 Population Health Research Institute"/>
 <result pre="spike binding complex, Endosomal acidification â€ 1 Azithromycin â€ 2" exact="Chloroquine" post="Phase 3 Population Health Research Institute NCT04324463 ACE2 and"/>
 <result pre="NCT04324463 ACE2 and spike binding complex, Endosomal acidification â€ 1" exact="Azithromycin" post="â€ 2 Hydroxychloroquine Phase 4 Chronic Obstructive Pulmonary Disease"/>
 <result pre="spike binding complex, Endosomal acidification â€ 1 Azithromycin â€ 2" exact="Hydroxychloroquine" post="Phase 4 Chronic Obstructive Pulmonary Disease Trial Network, Denmark"/>
 <result pre="NCT04322396 ACE2 and spike binding complex, Endosomal acidification â€ 1" exact="Hydroxychloroquine" post="+ azithromycin â€ 2 Hydroxychloroquine Phase 3 Hospital Israelita"/>
 <result pre="and spike binding complex, Endosomal acidification â€ 1 Hydroxychloroquine +" exact="azithromycin" post="â€ 2 Hydroxychloroquine Phase 3 Hospital Israelita Albert Einstein,"/>
 <result pre="complex, Endosomal acidification â€ 1 Hydroxychloroquine + azithromycin â€ 2" exact="Hydroxychloroquine" post="Phase 3 Hospital Israelita Albert Einstein, EMS, Hospital do"/>
 <result pre="Care Network, EMS NCT04321278, NCT04322123 Endosomal acidification, RdRp â€ 1" exact="Hydroxychloroquine" post="â€ 2 Remdesivir Phase 2, Phase 3 Oslo University"/>
 <result pre="â€ 1 Carrimycin â€ 2 lopinavir/ritonavir tablets or Arbidol or" exact="chloroquine" post="phosphate Phase 4 Beijing YouAn Hospital, Shenyang Tonglian Group"/>
 <result pre="might be a potential therapeutic strategy. Several therapeutics such as" exact="Chloroquine" post="(CQ), a wellâ€�studied lysosomotropic antimalarial drug, and its derivatives"/>
 <result pre="Chloroquine (CQ), a wellâ€�studied lysosomotropic antimalarial drug, and its derivatives" exact="hydroxychloroquine" post="and colchicine would be an option for blocking this"/>
 <result pre="(Savarino, Boelaert, Cassone, Majori, &amp;amp; Cauda, 2003). Although CQ and" exact="hydroxychloroquine" post="were found to be effective against SARSâ€�CoVâ€�2 (Gautret et"/>
 <result pre="evidence claimed some unprecedented effects. A recent study reported that" exact="hydroxychloroquine" post="(either alone or in combination with azithromycin) showed no"/>
 <result pre="2020), instead was linked with increased overall mortality (27.8% in" exact="hydroxychloroquine" post="and 22.1% in hydroxychloroquine plus azithromycin versus 11.4% in"/>
 <result pre="with increased overall mortality (27.8% in hydroxychloroquine and 22.1% in" exact="hydroxychloroquine" post="plus azithromycin versus 11.4% in the control group). A"/>
 <result pre="overall mortality (27.8% in hydroxychloroquine and 22.1% in hydroxychloroquine plus" exact="azithromycin" post="versus 11.4% in the control group). A multinational, observational,"/>
 <result pre="observational, realâ€�world study of patients with COVIDâ€�19 also claimed that" exact="hydroxychloroquine" post="or chloroquine showed no evidence of benefit, rather it"/>
 <result pre="study of patients with COVIDâ€�19 also claimed that hydroxychloroquine or" exact="chloroquine" post="showed no evidence of benefit, rather it was associated"/>
 <result pre="Moreover, a recent systematic review found no difference between the" exact="hydroxychloroquine" post="treated group and an untreated group of COVIDâ€�19 patients"/>
 <result pre="al., 2020). WHO had recently postponed further clinical trials on" exact="hydroxychloroquine" post="due to unexpected results in previous trials, however, this"/>
 <result pre="treating COVIDâ€�19 (Tables 1 and 2). ASC09/Ritonavir, Lopinavir/Ritonavir, ASC09Fâ€‰+â€‰Oseltamivir, and" exact="Ritonavir" post="+ Oseltamivir are some protease inhibitor drug candidates that"/>
 <result pre="(Table 1). For example, monotherapy or combination of Lopinavir and" exact="Ritonavir" post="has been studied against MERSâ€�CoV both in vitro and"/>
 <result pre="al., 2014). Studies showed that the combination of Lopinavir and" exact="Ritonavir" post="with Ribavirin and Interferon alfa (IFNâ€�Î±) resulted in the"/>
 <result pre="Studies showed that the combination of Lopinavir and Ritonavir with" exact="Ribavirin" post="and Interferon alfa (IFNâ€�Î±) resulted in the survival of"/>
 <result pre="evaluate and compare the efficacy and safety of Lopinavir and" exact="Ritonavir" post="for COVIDâ€�19 patients (Table 3). A recent case report"/>
 <result pre="Pharmaceuticals Co., Ltd. NCT04261907 3CLpro â€ 1 ASC09Fâ€‰+â€‰Oseltamivir â€ 2" exact="Ritonavir" post="+ Oseltamivir â€ 3 Oseltamivir Phase 3 Tongji Hospital"/>
 <result pre="3 Oseltamivir Phase 3 Tongji Hospital NCT04261270 3CLpro Darunavir and" exact="Cobicistat" post="Phase 3 Shanghai Public Health Clinical Center NCT04252274 3CLpro"/>
 <result pre="3 Shanghai Public Health Clinical Center NCT04252274 3CLpro Ganovo +" exact="ritonavir" post="Â± interferon nebulization Phase 4 The Ninth Hospital of"/>
 <result pre="Co. Ltd. NCT04321174, NCT04295551 3CLpro â€ 1 Lopinavir/ritonavir â€ 2" exact="Hydroxychloroquine" post="sulfate Phase 2 Asan Medical Center NCT04307693 3CLpro â€"/>
 <result pre="Asan Medical Center NCT04307693 3CLpro â€ 1 Lopinavir/ritonavir â€ 2" exact="Hydroxychloroquine" post="sulfate â€ 3 Baricitinib (Janus kinase inhibitor) â€ 4"/>
 <result pre="(NIAID) NCT04323761, NCT04302766, NCT04315948, NCT04252664, NCT04257656, NCT04292899, NCT04292730, NCT04280705 RdRp" exact="Ribavirin" post="Not applicable Jiangsu Famous Medical Technology Co., Ltd. NCT04306497"/>
 <result pre="National Institute of Allergy and Infectious Diseases (NIAID) NCT03891420 RdRp" exact="Triazavirin" post="Phase 3 Health Commission of Heilongjiang province ChiCTR2000030001 Note:"/>
 <result pre="with the control arm (Cai et al., 2020). Remdesivir, an" exact="adenosine" post="nucleoside analog prodrug and developed by Gilead Sciences (Foster"/>
 <result pre="trials are undergoing to study the efficacy of Remdesivir and" exact="Ribavirin" post="for the treatment of SARSâ€�CoVâ€�2 as alone or in"/>
 <result pre="Negrin University Hospital, Li Ka Shing Knowledge Institute NCT04325061 Cytokine" exact="Methylprednisolone" post="Phase 2, Phase 3, Phase 4 Beijing Chao Yang"/>
 <result pre="(IFNAR) â€ 1 Recombinant human interferon Alphaâ€�1b â€ 2 thymosin" exact="alpha" post="1 Phase 3 Shanghai Jiao Tong University School of"/>
 <result pre="+ standard treatment Phase 2 Southeast University, China NCT04268537 Prostaglandins" exact="Naproxen" post="Phase 3 Assistance Publique â€� HÃƒÂ´pitaux de Paris NCT04325633"/>
 <result pre="need to be evaluated against SARSâ€�CoVâ€�2. However, recent hype on" exact="hydroxychloroquine" post="or chloroquine, for example, as COVIDâ€�19 therapy should be"/>
 <result pre="V. T., Meddeb, L., Mailhe, M., &amp;amp; Raoult, D. (2020)." exact="Hydroxychloroquine" post="and azithromycin as a treatment of COVIDâ€�19: Results of"/>
 <result pre="Meddeb, L., Mailhe, M., &amp;amp; Raoult, D. (2020). Hydroxychloroquine and" exact="azithromycin" post="as a treatment of COVIDâ€�19: Results of an openâ€�label"/>
 <result pre="I., &amp;amp; Jang, H. C. (2016). Combination therapy with lopinavir/ritonavir," exact="ribavirin" post="and interferonâ€�Î± for Middle East respiratory syndrome. Antiviral Therapy,"/>
 <result pre="W., Sutton, S. S., &amp;amp; Ambati, J. (2020). Outcomes of" exact="hydroxychloroquine" post="usage in United States veterans hospitalized with Covidâ€�19. medRxiv"/>
 <result pre="Desai, S. S., Ruschitzka, F., &amp;amp; Patel, A. N. (2020)." exact="Hydroxychloroquine" post="or chloroquine with or without a macrolide for treatment"/>
 <result pre="S., Ruschitzka, F., &amp;amp; Patel, A. N. (2020). Hydroxychloroquine or" exact="chloroquine" post="with or without a macrolide for treatment of COVIDâ€�19:"/>
 <result pre="rapid antiviral clearance or clinical benefit with the combination of" exact="hydroxychloroquine" post="and azithromycin in patients with severe COVIDâ€�19 infection. MÃ©decine"/>
 <result pre="clearance or clinical benefit with the combination of hydroxychloroquine and" exact="azithromycin" post="in patients with severe COVIDâ€�19 infection. MÃ©decine et Maladies"/>
 <result pre="Cassone, A., Majori, G., &amp;amp; Cauda, R. (2003). Effects of" exact="chloroquine" post="on viral infections: An old drug against today's diseases?The"/>
 <result pre="Discovery and synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1â€�f][triazinâ€�4â€�amino]" exact="adenine" post="Câ€�nucleoside (GSâ€�5734) for the treatment of Ebola and emerging"/>
 <result pre="Y. N., &amp;amp; Hong, Z. (2001). Mechanisms of action of" exact="ribavirin" post="in antiviral therapies. Antiviral Chemistry and Chemotherapy, 12(5), 261â€&quot;272."/>
 <result pre="Liu, J., Xu, M., &amp;amp; Xiao, G. (2020). Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019â€�nCoV) in"/>
 <result pre="vitro antiviral activity and projection of optimized dosing Design of" exact="Hydroxychloroquine" post="for the treatment of severe acute respiratory syndrome coronavirus"/>
</results>
